The Link Between GLP-1 Agonists and Gallstone Formation Emerging evidence suggests a potential association between GLP-1 receptor agonist therapy and an increased incidence of gallbladder-related complications, including cholesterol gallstone formation and acute cholecystitis
ST: Diet and mental health research in the Thuret lab is funded by grants awarded by the Medical Research Council UK (MR/N030087/1 and MR/S00484X/1, the European Unions H2020 Joint Programming Initiative A Healthy Diet for a Healthy Life and the Network of Centres of Excellence in Neurodegeneration (COEN)
High-resolution LC-MS techniques enable precise molecular weight confirmation, peptide mapping, and structural characterization of GLP-1 therapeutics
Additionally, patients often overlook the importance of hydration, nutrient intake, and muscle preservation during weight loss
Primarily used to treat Type 2 diabetes and assist with obesity management through weight loss, this drug class is dominated by industry leaders such as Novo Nordisk and Eli Lilly and Company
Semaglutide & Cagrilintide Dosing: Beginner to Advanced Guide We discuss semaglutide and the specific nuances of cagrilintide dosing , which typically involves a ramp-up period starting from 0.25mg to 2.5mg